John T. Cavan is CFO at ContraVir Pharmaceuticals, Inc. (CTRV). They have made 3 open-market trades across 2 companies since 2017, most recently 2021-02-18.
CIK 0001503738
3 open-market purchases totalling $40K since 2017, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.